COVID-19 Convalescent Plasma Treatment Clinical Trial
Official title:
Analysis of the Efficacy and Tolerance of Covid-19 Convalescent Plasma and Monoclonal Antibodies in the Treatment of SARS-Cov2 Infections in Immunocompromised Patients
Data on the use of convalescent plasma in the treatment of covid-19 are scarce: the results of randomized studies involving mainly immunocompetent patients are disappointing, while case series or retrospective data on more selected patients , in particular immunocompromised patients suggest a benefit in these patients whose clinical manifestation seems essentially related to the uncontrolled infection and not the cytokine storm.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04616976 -
COVID-19 With Convalescent Plasma
|
||
| Terminated |
NCT04642014 -
Application of Convalescent Plasma in the Treatment of SARS CoV-2 Disease (COVID-19) With Evaluation of Therapy Effectiveness
|
N/A |